Drug news
BayerHealthCare filed new contraceptive patch in European Union
Bayer HealthCare has submitted an application for marketing authorization in the European Union for a new transparent low dose contraceptive patch (ethinylestradiol/ gestodene). France will serve as the reference member state in the decentralized procedure for gaining marketing authorization in countries in the European Union